(73) confirmed that gefitinib (a potent ABCG2 inhibitor) could inhibit ABCG2-mediated PpIX efflux from malignant brain tumor cells, thereby increasing intracellular PpIX levels and the effect of PDT, as presented in Figure 2. This evidence concerns the gene ABCG2 and brain neoplasm.